Utah Medical Products UTMD Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.
The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's deferred tax assets?
- Utah Medical Products (UTMD) reported deferred tax assets of $294K in Q1 2026.
- How has Utah Medical Products's deferred tax assets changed year-over-year?
- Utah Medical Products's deferred tax assets decreased by 23.6% year-over-year, from $385K to $294K.
- What is the long-term trend for Utah Medical Products's deferred tax assets?
- Over 4 years (2021 to 2025), Utah Medical Products's deferred tax assets has grown at a -24.8% compound annual growth rate (CAGR), from $4.12M to $1.32M.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.